We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.58%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.12B
AUM Growth
-$199M
(-3.7%)
Cap. Flow
-$200M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
24.54%
Holding
885
New
102
Increased
287
Reduced
309
Closed
94
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$25.9M |
| 2 |
Citizens Financial Group
CFG
|
+$23.8M |
| 3 |
EOG Resources
EOG
|
+$23.7M |
| 4 |
Independent Bank Group, Inc.
IBTX
|
+$18.4M |
| 5 |
Acuity Brands
AYI
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAV
B/E Aerospace Inc
BEAV
|
+$48.6M |
| 2 |
Ventas
VTR
|
+$42.2M |
| 3 |
Centene
CNC
|
+$38.9M |
| 4 |
Manhattan Associates
MANH
|
+$30.4M |
| 5 |
Salesforce
CRM
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.09% |
| 2 | Financials | 14.79% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 14.11% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ELI
626
DELISTED
ELITE PHARMACEUTICAL
ELI
| $45K | ﹤0.01% |
293,180
| – | – |
2013 Q2
14 quarters
|
|
|
PLM
627
DELISTED
PolyMet Mining Corp.
PLM
| $36K | ﹤0.01% |
4,910
| – | – |
2013 Q2
14 quarters
|
|
628
Denison Mines
DNN
$2.14B
| $13K | ﹤0.01% |
25,000
| – | – |
2013 Q2
14 quarters
|
|
629
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
| $10K | ﹤0.01% |
+19,205
| New | +$15.3K |
2016 Q4
0 quarters
|
|
|
BLPH
630
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $7K | ﹤0.01% |
833
| – | – |
2016 Q1
3 quarters
|
|
|
QMM
631
DELISTED
QUATERRA RESOURCES INC LTD
QMM
| $7K | ﹤0.01% |
136,175
| – | – |
2013 Q2
14 quarters
|
|
|
GMO
632
DELISTED
General Moly, Inc.
GMO
| $3K | ﹤0.01% |
13,518
| – | – |
2013 Q2
14 quarters
|
|
|
GPIC
633
DELISTED
Gaming Partners International Corporation
GPIC
| $1K | ﹤0.01% |
310,000
-938,500
| -75% | -$10.6M |
2013 Q2
14 quarters
|
|
634
Alcoa
AA
$10.7B
| – | – |
-8,550
| Closed | -$208K | – |
|
635
American Airlines Group
AAL
$8.13B
| – | – |
-6,769
| Closed | -$248K | – |
|
636
Applied Materials
AMAT
$341B
| – | – |
-11,292
| Closed | -$340K | – |
|
637
American Water Works
AWK
$26.4B
| – | – |
-3,483
| Closed | -$261K | – |
|
638
Bank of Montreal
BMO
$115B
| – | – |
-3,600
| Closed | -$236K | – |
|
639
Conagra Brands
CAG
$6.77B
| – | – |
-7,145
| Closed | -$262K | – |
|
640
Crown Castle
CCI
$34B
| – | – |
-129,286
| Closed | -$12.2M | – |
|
|
641
Centene
CNC
$34.8B
| – | – |
-1,161,198
| Closed | -$38.9M | – |
|
642
Cintas
CTAS
$84.6B
| – | – |
-23,404
| Closed | -$659K | – |
|
643
DHT Holdings
DHT
$3.78B
| – | – |
-10,000
| Closed | -$42K | – |
|
644
Digital Realty Trust
DLR
$64.7B
| – | – |
-2,701
| Closed | -$262K | – |
|
645
Fortune Brands Innovations
FBIN
$4.77B
| – | – |
-4,551
| Closed | -$226K | – |
|
646
First Hawaiian
FHB
$3.03B
| – | – |
-7,450
| Closed | -$200K | – |
|
647
Gaming and Leisure Properties
GLPI
$11.4B
| – | – |
-6,000
| Closed | -$201K | – |
|
648
Genworth Financial
GNW
$3.38B
| – | – |
-10,000
| Closed | -$50K | – |
|
649
Global Payments
GPN
$22.3B
| – | – |
-4,373
| Closed | -$336K | – |
|
650
Infosys
INFY
$49.1B
| – | – |
-33,782
| Closed | -$267K | – |
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, Geneva Advisors held 885 positions worth $5.12B, down 3.7% from $5.32B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors withdrew a net $200M in Q4 2016, closing 94 positions and reducing 309 holdings. Its most notable exit was Ventas, an estimated $42.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Geneva Advisors opened a new position in Citizens Financial Group worth $28M.
- Geneva Advisors's largest Q4 2016 buy was Citizens Financial Group: 786,703 shares worth $28M.
- Geneva Advisors added most to Celgene Corp in Q4 2016, an estimated $25.9M increase.
- Geneva Advisors's biggest Q4 2016 reduction was B/E Aerospace Inc, cutting an estimated $48.6M.
- Geneva Advisors fully exited Ventas in Q4 2016, selling an estimated $42.2M.
- Geneva Advisors's ten largest holdings make up 25% of its $5.12B portfolio in Q4 2016.
- Geneva Advisors opened 102 new positions and closed 94 in Q4 2016.
- Geneva Advisors's portfolio value fell 3.7% quarter-over-quarter to $5.12B.
Based on Geneva Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.